Alcohol Drinking
Welcome,         Profile    Billing    Logout  
 22 Companies   16 Products   16 Products   10 Mechanisms of Action   3 Trials   538 News 


«123456789101112»
  • ||||||||||  Trial completion, Enrollment change:  Alcohol Consumption and Coronary Heart Disease Onset (clinicaltrials.gov) -  Dec 22, 2017   
    P=N/A,  N=35132, Completed, 
    Phase classification: P1/2 --> P=N/A | Trial primary completion date: Dec 2017 --> Dec 2018 Active, not recruiting --> Completed | N=64926 --> 35132
  • ||||||||||  Trial completion, Enrollment change:  ACT: Parent Interventions to Prevent Student Drinking (clinicaltrials.gov) -  Dec 15, 2017   
    P=N/A,  N=1900, Completed, 
    Phase classification: P3 --> P=N/A | N=387 --> 148 Active, not recruiting --> Completed | N=1200 --> 1900
  • ||||||||||  topiramate / Generic mfg.
    Enrollment change, Trial termination, Trial primary completion date:  TOPMRI: Topiramate's Effects on Heavy Drinking (clinicaltrials.gov) -  Dec 11, 2017   
    P2,  N=1, Terminated, 
    Active, not recruiting --> Completed N=40 --> 1 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Mar 2017; We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo controlled, double-blind, trial of topiramate in heavy drinkers.
  • ||||||||||  NN1213 / Novo Nordisk
    Trial completion:  Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women (clinicaltrials.gov) -  Dec 5, 2017   
    P=N/A,  N=148, Completed, 
    N=40 --> 1 | Recruiting --> Terminated | Trial primary completion date: Mar 2019 --> Mar 2017; We terminated the study to run it as a sub-study of NCT02371889, which is a 13 week, placebo controlled, double-blind, trial of topiramate in heavy drinkers. Recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Alcohol Consumption and Coronary Heart Disease Onset (clinicaltrials.gov) -  Oct 27, 2017   
    P=N/A,  N=64926, Active, not recruiting, 
    Active, not recruiting --> Completed Trial primary completion date: Jun 2017 --> Oct 2017
  • ||||||||||  Trial completion, Phase classification, Trial primary completion date:  PROFETHYL/2: Dose-response Effect of Alcohol Ingestion on Steroid Profile (clinicaltrials.gov) -  Oct 6, 2017   
    P=N/A,  N=12, Completed, 
    N=76 --> 38 | Trial primary completion date: Mar 2017 --> Nov 2017 Recruiting --> Completed | Phase classification: P1 --> PN/A | Trial primary completion date: May 2017 --> Nov 2016
  • ||||||||||  Trial completion:  Web-AME: Web-Based Adolescent Motivational Enhancement Study (clinicaltrials.gov) -  Oct 5, 2017   
    P=N/A,  N=148, Completed, 
    Recruiting --> Completed | Phase classification: P1 --> PN/A | Trial primary completion date: May 2017 --> Nov 2016 Active, not recruiting --> Completed
  • ||||||||||  Trial completion:  Emerging Adults Who Use Alcohol and Marijuana (clinicaltrials.gov) -  Sep 18, 2017   
    P3,  N=566, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Trial primary completion date:  Computerized Tool for Preventing Prenatal Drinking (clinicaltrials.gov) -  Sep 11, 2017   
    P=N/A,  N=200, Active, not recruiting, 
    Recruiting --> Active, not recruiting | N=75 --> 36 Trial primary completion date: Aug 2017 --> Aug 2018
  • ||||||||||  Trial primary completion date:  Computerized Tool for Preventing Prenatal Drinking (clinicaltrials.gov) -  Aug 31, 2017   
    P=N/A,  N=200, Active, not recruiting, 
    Trial primary completion date: Aug 2017 --> Aug 2018 Trial primary completion date: May 2017 --> Aug 2017
  • ||||||||||  Enrollment closed, Enrollment change:  Community-Based Integrated Treatment for Adolescents (clinicaltrials.gov) -  Aug 1, 2017   
    P1,  N=114, Active, not recruiting, 
    N=40 --> 20 Recruiting --> Active, not recruiting | N=200 --> 114
  • ||||||||||  Acomplia (rimonabant) / Sanofi
    Trial completion:  Rimonabant to Reduce Alcohol Consumption (clinicaltrials.gov) -  Jun 30, 2017   
    P2,  N=54, Completed, 
    Phase classification: P2 --> P=N/A Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Phase classification, Enrollment change, Trial primary completion date:  SK: Contingency Management to Reduce Alcohol Use in a Soup Kitchen Sample (clinicaltrials.gov) -  Jun 26, 2017   
    P=N/A,  N=27, Completed, 
    Active, not recruiting --> Completed Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | N=40 --> 27 | Trial primary completion date: Jul 2017 --> Nov 2016
  • ||||||||||  naltrexone / Generic mfg.
    Trial completion, Compliance:  Naltrexone for Medication Compliance Among HIV-infected Men With Alcohol Use Disorder (clinicaltrials.gov) -  Jun 16, 2017   
    P4,  N=159, Completed, 
    Active, not recruiting --> Completed | Phase classification: P2 --> PN/A | N=40 --> 27 | Trial primary completion date: Jul 2017 --> Nov 2016 Active, not recruiting --> Completed
  • ||||||||||  Trial completion, Enrollment change, Trial primary completion date:  Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers (clinicaltrials.gov) -  Jun 15, 2017   
    P2,  N=18, Completed, 
    Recruiting --> Active, not recruiting Recruiting --> Completed | N=124 --> 18 | Trial primary completion date: Sep 2020 --> Jun 2017